Labcorp, Charles River And FDA Launch Collaboration To Improve Drug Abuse Risk Assessment

Labcorp announced a research collaboration with the U.S. FDA and Charles River Laboratories to advance scientific methods for assessing whether new medicines have abuse potential. The initiative is intended to support safer drug development; the article excerpt provides no financial terms or market reaction.